logo

CDIO

Cardio Diagnostics·NASDAQ
--
--(--)
--
--(--)
3.95 / 10
Netural

Corporate fundamentals rate poor at 4.0/10. Beneficial factors: Revenue-MV and Profit-MV, though challenges appear in Current assets turnover ratio and Fixed assets turnover ratio. Resultant assessment: challenging.

Fundamental(3.95)SentimentTechnical

Analysis Checks(5/10)

Revenue-MV
Value-9.46
Score2/3
Weight25.91%
1M Return11.69%
Inventory turnover ratio
Value47.85
Score3/3
Weight9.98%
1M Return5.26%
Gross profit margin (%)
Value100.00
Score3/3
Weight22.82%
1M Return10.80%
Profit-MV
Value0.46
Score2/3
Weight17.00%
1M Return7.79%
PB-ROE
Value22.74
Score0/3
Weight7.76%
1M Return3.56%
Current assets turnover ratio
Value0.00
Score0/3
Weight-3.11%
1M Return-1.88%
Fixed assets turnover ratio
Value0.01
Score1/3
Weight-2.70%
1M Return-1.64%
Asset-MV
Value-0.50
Score0/3
Weight5.81%
1M Return2.94%
Cash-MV
Value-0.07
Score2/3
Weight17.03%
1M Return7.73%
Net profit / Total profit (%)
Value100.00
Score0/3
Weight-0.50%
1M Return-0.30%
Is CDIO undervalued or overvalued?
  • CDIO scores 3.95/10 on fundamentals and holds a Fair valuation at present. Backed by its -56.84% ROE, -41516.33% net margin, -0.36 P/E ratio, 0.28 P/B ratio, and 65.38% earnings growth, these metrics solidify its Netural investment rating.